期刊名
PHYTOTHERAPY RESEARCH

PHYTOTHER RES

ISSN / eISSN
0951-418X / 1099-1573
目标和范围
Phytotherapy Research is a monthly, international journal for the publication of original research papers, short communications, reviews and letters on medicinal plant research. Key areas of interest are pharmacology, toxicology, and the clinical applications of herbs and natural products in medicine, from case histories to full clinical trials, including studies of herb-drug interactions and other aspects of the safety of herbal medicines. Papers concerned with the effects of common food ingredients and standardised plant extracts, including commercial products, are particularly welcome, as are mechanistic studies on isolated natural products.

Short communications dealing with the pharmacology and screening of crude or uncharacterised extracts will be considered for publication only if they are clearly of interest to our international readership and are not deemed more suitable for a regional audience.

Phytotherapy Research does not publish agricultural, phytochemical, structure elucidation, quality control or botanical identification papers unless directly pertinent to the pharmacological effects or overall safety of plant based medicines currently in use.
研究方向

药物化学

药学

CiteScore
11.80 查看趋势图
CiteScore 学科排名
类别 分区 排名
Pharmacology, Toxicology and Pharmaceutics - Pharmacology Q1 #24/301
Web of Science 核心合集
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
类别 (Journal Citation Reports 2023) 分区
CHEMISTRY, MEDICINAL - SCIE Q1
PHARMACOLOGY & PHARMACY - SCIE Q1
H-index
112
出版国家或地区
ENGLAND
出版商
John Wiley and Sons Ltd
出版周期
Monthly
出版年份
1987
年文章数
323
Open Access
NO
通讯方式
JOHN WILEY & SONS LTD, THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ
认证评论
注: 认证评论选取于全球各个学术评论平台和社交媒体。
Submission in mid-June, revision in late July, it is a minor revision. After revision, it will be accepted in August. It requires a high level of language proficiency and the basic need for a professional native speaker to proofread, even if we have already written it carefully. This journal has a good reputation in the field of traditional Chinese medicine and is basically on par with Phytomedicine, which has just been upgraded to the first category of the Chinese Academy of Sciences. Its impact factor is higher than that of the Journal of Ethnopharmacology, but the latter is a well-established and reputable publication. One year, Yangtze University even listed it as a low-risk journal, which is quite absurd. It must be said that this CJDX is quite impressive, not only in terms of reputation but also in terms of its influence.
2023-02-27
Submitted: April 25, 2023
Final revisions submitted: July 20, 2023
Accepted: August 6, 2023
The first round of revisions came back on May 31st with feedback from 7 reviewers and about 30 modifications suggested by the editor, which can be considered as 8 reviewers.
The second round of revisions was on July 15th, with 5 reviewers raising around 10 additional questions. The revisions were sent back on July 20th and accepted on August 6th.
On August 9th, an email was sent to confirm the license agreement and the article entered the production stage, receiving a DOI number.
2023-08-09

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started